Piperazine derivatives and their use as therapeutic agents
US7456180B2 · kind B2 · utility
15Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2004 |
| Grant date | Nov 25, 2008 |
| Priority date | — |
| Expiry date | May 14, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where G, J, L, M, x, y, W, V, R2, R3, R4, R5, R6, R7, R8, R8a, R9, R9a, R10, R10a, R11 and R11a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.